Status:
COMPLETED
Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers
Lead Sponsor:
Banner Health
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Eligibility:
All Genders
50-80 years
Brief Summary
This is an observational study that will collect blood from a finger prick (Capitainer SEP10 single channel device) and assess the accuracy of pTau-217 testing in comparison to previously collected ve...
Detailed Description
Blood biomarkers offer a less invasive and cheaper method for identifying Alzheimer's disease (AD)-related pathophysiological changes. AD blood biomarkers are already being adopted by clinical practic...
Eligibility Criteria
Inclusion
- Able and willing to provide informed consent for the eDROP-AD study.
- Enrolled in the Draw-10 study at Banner Alzheimer's Institute-Phoenix and provided at least one venous blood sample.
- Able and willing to fully comply with study procedures defined in this protocol.
- Written and spoken fluency in the English language.
Exclusion
- \-
Key Trial Info
Start Date :
September 29 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 12 2025
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT07187921
Start Date
September 29 2025
End Date
November 12 2025
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner Alzheimer's Institute
Phoenix, Arizona, United States, 85006